These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30511248)

  • 21. Targeting endotoxin in the treatment of sepsis.
    Rachoin JS; Schorr CA; Dellinger RP
    Subcell Biochem; 2010; 53():323-38. PubMed ID: 20593274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of polymyxin B immobilized fiber on urinary N-acetyl-beta-glucosaminidase in patients with severe sepsis.
    Nakamura T; Kawagoe Y; Matsuda T; Ueda Y; Koide H
    ASAIO J; 2004; 50(6):563-7. PubMed ID: 15672789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Another antiendotoxin strategy to be added to the list.
    Vincent JL; Cohen J
    Crit Care Med; 1997 Dec; 25(12):1949-50. PubMed ID: 9403740
    [No Abstract]   [Full Text] [Related]  

  • 24. [Endotoxin eliminating therapy in patients with severe sepsis--direct hemoperfusion using polymyxin B immobilized fiber column].
    Kodama M; Tani T; Maekawa K; Hirasawa H; Otsuka T; Takahashi Y; Kaneko M
    Nihon Geka Gakkai Zasshi; 1995 May; 96(5):277-85. PubMed ID: 7596338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical effects of polymyxin B-immobilized fiber column in septic patients.
    Cruz DN; Bellomo R; Ronco C
    Contrib Nephrol; 2007; 156():444-51. PubMed ID: 17464156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood purification therapy for sepsis.
    Sakata H; Yonekawa M; Kawamura A
    Transfus Apher Sci; 2006 Dec; 35(3):245-51. PubMed ID: 17110167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of polymyxin B-immobilized fiber on serum phosphate concentrations in patients with sepsis.
    Shimada N; Nakamura T; Takahashi Y; Tanaka A; Shoji H; Sekizuka K; Ebihara I; Koide H
    Nephron; 2000 Nov; 86(3):359-60. PubMed ID: 11096302
    [No Abstract]   [Full Text] [Related]  

  • 28. Endotoxin removal by toraymyxin.
    Kunitomo T; Shoji H
    Contrib Nephrol; 2001; (132):415-20. PubMed ID: 11395910
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of hemoperfusion with polymyxin B-immobilized fiber on plasma endothelin-1 and endothelin-1 mRNA in monocytes from patients with sepsis.
    Ebihara I; Nakamura T; Shimada N; Shoji H; Koide H
    Am J Kidney Dis; 1998 Dec; 32(6):953-61. PubMed ID: 9856510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymyxin B-immobilised haemoperfusion and mortality in critically ill patients with sepsis/septic shock: a protocol for a systematic review and meta-analysis.
    Fujii T; Ganeko R; Kataoka Y; Featherstone R; Bagshaw SM; Furukawa TA
    BMJ Open; 2016 Nov; 6(11):e012908. PubMed ID: 27872122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical effects of direct hemoperfusion using a polymyxin-B immobilized column in solid organ transplanted patients with signs of severe sepsis and septic shock. A pilot study.
    Ruberto F; Pugliese F; D'Alio A; Martelli S; Bruno K; Marcellino V; Summonti D; Celli P; Perrella S; Cappannoli A; Pietropaoli C; Tosi A; Diana B; Novelli G; Rossi M; Ginanni-Corradini S; Ferretti G; Berloco PB; Pietropaoli P
    Int J Artif Organs; 2007 Oct; 30(10):915-22. PubMed ID: 17992653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of PMX-DHP treatment for patients with directly induced acute respiratory distress syndrome.
    Tsushima K; Kubo K; Yoshikawa S; Koizumi T; Yasuo M; Furuya S; Hora K
    Ther Apher Dial; 2007 Apr; 11(2):138-45. PubMed ID: 17381535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical effects of intramuscular administration of a small dose of polymyxin B to patients with endotoxemia.
    Endo S; Inada K; Kikuchi M; Yamada Y; Takakuwa T; Nakae H; Inoue Y; Kasai T; Terashima M; Yamashita H
    Res Commun Chem Pathol Pharmacol; 1994 Feb; 83(2):223-35. PubMed ID: 8202633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endotoxin removal: how far from the evidence? The EUPHAS 2 Project.
    Martin EL; Cruz DN; Monti G; Casella G; Vesconi S; Ranieri VM; Ronco C; Antonelli M
    Contrib Nephrol; 2010; 167():119-125. PubMed ID: 20519906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose polymyxin: an option for therapy of Gram-negative sepsis.
    Harm S; Gabor F; Hartmann J
    Innate Immun; 2016 May; 22(4):274-83. PubMed ID: 26993088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Effects of a Longer Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Therapy for Severe Sepsis and Septic Shock.
    Yamashita C; Hara Y; Kuriyama N; Nakamura T; Nishida O
    Ther Apher Dial; 2015 Aug; 19(4):316-23. PubMed ID: 26386218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of an endotoxin-removing column containing immobilized polymyxin B fiber in a patient with septic shock from gram-positive infection.
    Iwama H; Komatsu T
    Acta Anaesthesiol Scand; 1998 May; 42(5):590-3. PubMed ID: 9605378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo effect of polymyxin B on pertussis vaccine.
    Larter WE; Corrigan JJ; Fulginiti VA
    Am J Dis Child; 1984 Mar; 138(3):281-3. PubMed ID: 6322572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endotoxin removal by polymyxin B immobilized cartridge inactivates circulating proapoptotic factors.
    Martin EL; Ranieri VM
    Contrib Nephrol; 2010; 167():65-76. PubMed ID: 20519900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Selective hemoperfusion in gram-negative severe sepsis of patients after cardiac surgery: a prospective randomized study].
    Iarustovskiĭ MB; Abramian MV; Popok ZV; Nazarova EI; Stupchenko OS; Popov DA; Pliushch MG
    Anesteziol Reanimatol; 2010; (5):60-5. PubMed ID: 21395144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.